Establishment Labs Holdings Inc. (ESTA)
Establishment Labs Holdings Inc. (ESTA) Q1 2026 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Q1 2026 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.7 per share a year ago.
Establishment Labs Insider Sells 37,500 Shares as Stock Jumps 128% in a Year
37,500 shares were sold indirectly for a total transaction value of approximately $2.45 million on April 14, 2026. All shares sold were indirectly held via Sariel Group Ltd, with no direct shares sold; after the trade, the insider retains 45,193 direct shares and 1,182,504 indirect shares, per the Form 4.
Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.98 per share a year ago.
Establishment Labs Holdings Inc. (ESTA) Q4 2025 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Q4 2025 Earnings Call Transcript
Establishment Labs: The Pivot From Growth To Profitable Scale
Establishment Labs is transitioning to positive cash flow, ending its cash burn era and justifying its premium valuation. ESTA achieved 20% U.S. breast augmentation market share in under 18 months, outpacing historical competitors and establishing a robust commercial platform. Expansion into the reconstruction segment and minimally invasive procedures is set to double ESTA's addressable market and drive at least 25% annual revenue growth through 2027.
Establishment Labs Holdings Inc. (ESTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Establishment Labs Holdings Inc. (ESTA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ESTA Shares Dip Despite FDA Filing for Motiva Breast Reconstruction
Establishment Labs files Motiva breast implants with the FDA for reconstruction, targeting expansion beyond elective augmentation into a clinically necessary market.
Establishment Labs Holdings Inc. (ESTA) Q3 2025 Earnings Call Transcript
Establishment Labs Holdings Inc. ( ESTA ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Rajbir Denhoy - Chief Financial Officer Filippo Caldini - CEO & Director Conference Call Participants Anthony Petrone - Mizuho Americas LLC Joshua Jennings - TD Cowen, Research Division K. Gong - JPMorgan Chase & Co, Research Division Sam Eiber - BTIG, LLC, Research Division Mason Carrico - Stephens Inc., Research Division Michael Matson - Needham & Company, LLC, Research Division Presentation Operator Good afternoon.
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.59 per share a year ago.
Establishment Labs Holdings Inc. (ESTA) Q2 2025 Earnings Call Transcript
Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Fillipo Peter Caldini - CEO & Director Rajbir Singh Denhoy - Chief Financial Officer Conference Call Participants Anthony Charles Petrone - Mizuho Americas LLC Joshua Thomas Jennings - TD Cowen, Research Division K. Gong - JPMorgan Chase & Co, Research Division Mason Owen Carrico - Stephens Inc., Research Division Matthew Charles Taylor - UBS Investment Bank, Research Division Mike Matson - Unidentified Company Sam Shimon Eiber - BTIG, LLC, Research Division Operator Good morning.
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Misses Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.62 per share a year ago.
